Share the article
twitter-iconcopy-link-iconprint-icon
share-icon
Investment bankingJanuary 2 2019

JPMorgan leveraged finance desk leads new era of LBOs

Leveraged buyouts have a chequered history but JPMorgan – which acted in the mega-deals of Refinitiv and AkzoNobel Specialty Chemicals – argues that both were reasonably structured and the market is different from a decade ago. Edward Russell-Walling reports.
Share the article
twitter-iconcopy-link-iconprint-icon
share-icon

Mega-deals have their own cycle, it seems, with the stars lining up for them every decade or so. Two-thousand and eighteen saw a reopening of the mega-deal window, ushering in, in turn, the two largest leveraged buyout (LBO) financings of the past 10 years. JPMorgan was lead left bookrunner on the junk bond element of both.

“There is a point in time when you can do mega-deals,” says Daniel Schlumberger, JPMorgan’s head of leveraged finance for European sponsors. “Whether you believe in cycles or not, there is a window every 10 years.”

To continue reading, join our community and benefit from

  • In-depth coverage across key markets
  • Comments from financial leaders and policymakers worldwide
  • Regional/country bank rankings and awards
Activate your free trial